In case of anaphylactic shock, symptomatic treatment (e.g. adrenaline or corticosteroids) should be administered.

Special precautions to be taken by the person administering the veterinary medicinal product to animals:

Care should be taken when handling the product to avoid self-injection. In case of accidental self-injection, seek medical advice, and show the package leaflet. Wash hands after handling the product.

Studies in laboratory animals exhibited teratogenic effects after the administration of eCG. Pregnant women, those intending to become pregnant, or whose pregnancy status is unknown, should not use the product. Accidental spillage on the skin should be washed off immediately with soap and water.

Adverse reactions:

eCG is an exogenous protein for species other than equine. Therefore, antigen-antibody reactions may result. In very rare cases, repeated administrations of eCG can provoke anaphylactic shock.

Use during pregnancy or lactation:

Studies in laboratory animals have shown teratogenic effects after administration of eCG.

The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Do not use during pregnancy.

Overdose:

Administration of higher doses than recommended doses may increase the risk of twins in cattle and triplets in sheep.

Withdrawal period:

Meat and offal: zero days

Milk: zero days